Aberg ND, Brywe KG, Isgaar J (2006). Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53-80.
Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M (2006). Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in pa-tients with multiple sclerosis. Brain 129:2620-2627.
Ahmed N, Latifi A, Riley CB, Findlay JK, Quinn MA (2010). Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer. J Ovarian Res 3:17.
Allamargot C, Pouplard-Barthelaix A, Fressinaud C (2001). A single intracerebral mi-croinjection of platelet-derived growth factor (PDGF) accelerates the rate of re-myelination in vivo. Brain Res 918:28-39.
Anderson CM, Nedergaard M (2003). Astrocyte-mediated control of cerebral microcir-culation. Trends Neurosci 26:340-344.
Andjelkovic AV, Nikolic B, Pachter JS, Zecevic N (1998). Macrophages/microglial cells in human central nervous system during development: an immunohistochem-ical study. Brain Res 814:13-25.
Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to re-pair demyelinated lesions in the CNS. Science 306:2111-2115.
Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA (2010).
Glial and neuronal control of brain blood flow. Nature 468:232-243.
50 Barnett SC, Linington C (2013). Myelination: Do astrocytes play a role? The
Neurosci-entist 19:442-450.
Batoulis H, Recks MS, Addicks K, Kuerten S (2011). Experimental autoimmune en-cephalomyelitis-achievements and prospective advances. APMIS 119:819-830.
Blakemore WF (1974). Pattern of remyelination in the CNS. Nature 249:577-578.
Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ (2003). Intracortical multiple sclero-sis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9:323-331.
Bögler O, Wren D, Barnett SC, Land H, Noble M (1990). Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oli-godendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368-6372.
Bozzali M, Cercignani M, Sormani MP, Comi G, Filippi M (2002). Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am J Neuroradiol 23:985-988.
Brosnan CF, Raine CS (2013). The astrocyte in multiple sclerosis revisited. Glia 61:453–465.
Bruce CC, Zhao C, Franklin RJ (2010). Remyelination — an effective means of neuro-protection. Horm Behav 57:56-62.
Brüstle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD (1999). Embryonic stem cell-derived glial precursors: a source of my-elinating transplants. Science 285:754-756.
51 Budka, H (1983). Immunohistological demonstration of serum proteins and structural and viral antigens in paraffin sections of nervous tissues. Ann NY Acad Sci 420:
176-184.
Bush TG, Savidge TC, Freeman TC, Cox HJ, Campbell EA, Mucke L, Johnson MH, Sofroniew MV (1998). Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93:189-201.
Bush TG, Sofroniew MV, Blumauer N, Lawrence Kruger, Mucke L, Johnson MH (1999). Genetically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice. Brain Res 835:91-95.
Bushong EA, Martone ME, Jones YZ, Ellisman MH (2002). Protoplasmic Astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22:183-192.
Buttermore ED, Thaxton CL, Bhat MA (2013). Organization and maintenance of mo-lecular domains in myelinated axons. J Neurosci Res 2013 Feb 13. doi:
10.1002/jnr.23197.
Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M (2009). Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144-1150.
Carlton WW (1966). Response of mice to the chelating agents sodium diethyldithiocar-bamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone. Toxicol Appl Pharmacol 8:512-521.
Carpino A, Bilinska B, Siciliano L, Maggiolini M, Rago V (2004). Immunolocalization of estrogen receptor beta in the epididymis of mature and immature pigs. Folia Histochem Cytobiol 42:13-17.
52 Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD (2012). Cortical Remyelination: A new target for repair therapies in Multiple Sclerosis. Ann Neurol 72:918-926.
Chesik D, De Keyser J, Wilczak N (2008). Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J Mol Neurosci 35:81-90.
Compston A, Coles A (2008). Multiple sclerosis. Lancet 372:1502-1517.
Cui QL, Almazan G (2009). IGF-I induced oligodendrocyte progenitor proliferation re-quires PI3K/Akt, MEK/ERK, and Scr-like tyrosine kinases. J Neurochem 100:1480-1493.
Dean G, Kurtzke JF (1971). On the risk of multiple sclerosis according to age at immi-gration to South Africa. Br Med J 3:725-729.
De Keyser J, Laureys G, Demol F, Wilczak N, Mostert J, Clinckers R (2010). Astro-cytes as potential targets to suppress inflammatory demyelinating lesions in mul-tiple sclerosis. Neurochem Int 57:446-450.
Eng LF (1985). Glial fibrillary acidic protein (GFAP): the major protein of glial inter-mediate filaments in differentiated astrocytes. J. Neuroimmunol 8:203-214. Fancy SP, Zhao C, Franklin RJ (2004). Increased expression of Nkx2.2 and Olig2 identi-fies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27:247-254.
Fazekas F, Barkhof F, Filippi M, Grossmann RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH (1999). The contribution of mag-netic resonance imaging to the diagnosis of multiple sclerosis. Neurology 53:448-456.
53 ffrench-Constant C, Raff MC (1986a). The oligodendrocyte-type-2 astrocyte cell
line-age is specialized for myelination. Nature 323:335-338.
ffrench-Constant C, Raff MC (1986b). Proliferating bipotential glial progenitor cells in-adult rat optic nerve. Nature 319:499-502.
Franklin RJ and ffrench-Constant C (2008). Remyelination in the CNS: from biology to therapy. Nature reviews, Neuroscience 9:839-855.
Franklin RJ, Kotter MR (2008). The biology of CNS remyelination: the key to therapeu-tic advances. J Neurol 255 (Suppl 1):19-25.
Genain CP, Cannella B, Hauser SL, Raine CS (1999). Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5:170-175.
Glezer I, Lapointe A, Rivest S (2006). Innate immunity triggers oligodendrocyte pro-genitor reactivity and confines damages to brain injuries. FASEB J 20:750-752 .
Groves AK, Barnett SC, Franklin RJ, Cranq AJ, Mayer M, Blakemore WF, Noble M (1993). Repair of demyelinated lesions by transplantation of purified O-2A pro-genitor cells. Nature 362:453-455.
Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M (2009). Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283:127-174.
Halassa MM, Fellin T, Takano H, Dong JH, Haydon PG (2007). Synaptic islands de-fined by the territory of a single astrocyte. J Neurosci 27:6473-6477.
Hammang JP, Archer DR, Duncan I (1997). Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Expb Neu-rol 147:84-95.
54 Hartmann W, Kluge H (1982). Principles for the evaluation and differentiation of single protein findings in the cerebrospinal fluid with the examples of IgG, IgA, IgM and transferrin. Psychiatr Neurol Med Psychol (Leipz.) 34:395-408.
Hibbits N, Yoshino J, Le TQ, Armstrong RC (2012). Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4:393-408.
Hinks GL, Franklin RJM (1999). Distinctive patterns of PDGF-A, FGF-2, IGF-I and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14:153-168.
Hiremath MM, Saito Y, Knapp GW, Ting JP, Matsushima GK (1998). Micro-glia/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38-49.
Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH (2000). Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20:2218-2228.
Irvine KA, Blakemore WF (2008). Remyelination protects axons from demyelination-associated axon degeneration. Brain 131:1464-1477.
Jadasz JJ, Aigner L, Rivera FJ, Küry P (2012). The remyelination Philosopher's Stone:
stem and progenitor cell therapies for multiple sclerosis. Cell Tissue Res 349:331-347.
Jeffery ND, Blakemore WF (1997). Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120:27-37.
Keegan BM, Noseworthy JH (2002). Multiple Sclerosis. Annual reviews 53:285-302.
55 Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999). Cortical
le-sions in multiple sclerosis. Brain 122:17-26.
Kimelberg HK (2007). Supportive or information-processing functions of the mature protoplasmic astrocyte in the mammalian CNS? A critical appraisal. Neuron Glia Biol 3:181-189.
Kimelberg HK (2010). Functions of Mature Mammalian Astrocytes: A Current View.
The Neuroscientist 16:79-106.
Kimelberg HK, Nedergaard M (2010). Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338-353.
Knot HJ, Zimmermann PA, Nelson MT (1996). Extracellular K(+)-induced hyperpolar-izations and dilatations of rat coronary and cerebral arteries involve inward recti-fier K(+) channels. J Physiol 492:419-430.
Kotter MR, Li WW, Zhao C, Franklin RJM (2006). Myelin Impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328-332.
Kuhlmann T, Remington L, Maruschak B, Owens T, Bruck W (2007). Nogo-A is a reli-able oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 66:238-246.
Kurtzke JF (1975). A reassessment of the distribution of multiple sclerosis. Part one.
Acta Neurol Scand 51:110-136.
Lang J, Maeda Y, Bannermann P, Xu J, Horiuchi M, Pleasure D, Guo F (2013). Ade-nomatous polyposis coli regulates oligodendroglial development. J Neurosci 33:3113-3130.
56 Lassmann H (2013). Multiple sclerosis: Lessons from molecular neuropathology. Exp Neurol. Dec 14pii:S0014-4886(13)00361-0.doi: 10.1016/j.expneurol.2013.12.003.
[Epub ahead of print]
Levine JM, Reynolds R, Fawcett JW (2001). The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
Li W-W, Penderis J, Zhao C, Schumacher M, Franklin RJM (2006). Females remyelin-ate more efficiently than males following demyelination in the aged but not young adult CNS. Exp Neurol 202:250-254.
Liebetanz D, Merkler D (2006). Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 202:217-224 .
Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2009). Chronic toxic demye-lination in the central nervous system leads to axonal damage despite remye-lination. Neurosci Lett 453:120-125.
Ludwin SK, Kosek JC, Eng LF (1976). The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horse-radish peroxidase-labelled antibodies. J Comp Neurol 165:197-207.
Ludwin SK, Maitland M (1984). Long-term remyelination fails to reconstitute normal thickness ofcentral myelin sheaths. J Neurol Sci 64:193-198.
Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK (2000). Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.
J Neurosci 20:5703-5708.
Mason JL, Suzuki K, Chaplin DD, Matsushima GK (2001). Interleukin-1β promotes re-pair of the CNS. J Neurosci 21:7046-7052.
57 Matsushima GK, Morell P (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990). FGF modulates the PDGF driven pathway of oligodendrocyte development. Neuron 5:603-614.
McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N (1993). Regu-lation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann NY Acad Sci 692:321-334.
Mecha M, Carillo-Salinas FJ, Mestre L, Feliú A, Guaza C (2013). Viral models of mul-tiple sclerosis: Neurodegeneration and demyelination in mice infected with Theil-er's virus. Prog Neurobiol 101-102:46-64.
Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC (2000). Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62:241-256.
Mitew S, Hay CM, Peckham H, Xiao J, Koenning M, Emery B (2013). Mechanisms regulating the Development of oligodendrocytes and central nervous system mye-lin. Neuroscience Nov 22.
Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ (2011). How factors secreted from astrocytes impact myelin repair. J Neurosci Res 89:13-21.
Morell P, Barret CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK (1998). Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12:220-227.
Nair A, Frederick TJ, Miller SD (2008). Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 65:2702-2720.
58 Niehaus A, Shi J, Grzenkowski M, Diers-Fenger M, Archelos J, Hartung HP, Toyka K, Brück W, Trotter J (2000). Patients with active relapsingremitting multiple sclero-sis synthesize antibodies recognizing oligodendrocyte progenitor cell surface pro-tein: implications for remyelination. Ann Neurol 48:362-371.
Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, Castelijns JA, van Waesberghe JH, Ravid R, Polman CH, Barkhof F (2001). Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI histopathology and clinical phenotype. Brain 124:154-166.
Paxinos G, Franklin GBJ (2001). „The Mouse Brain in stereotaxic coordinates“. New York: Academic Press.
Pekny M, Nilsson M (2005). Astrocyte activation and reactive gliosis. Glia 50:427-434.
Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP and Linington C (1993). The de-myelinating potential of antibodies to myelin oligodendrocyte glycoprotein is re-lated to their ability to fix complement. Am J Pathol 143:555-64.
Quarles RH (2007). Myelin-associated Glycoprotein (MAG): past, present and beyond.
J Neurochem 100:1431-1448.
Raff MC, Abney ER, Fok-Sean J (1985). Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation.
Cell 42:61-69.
Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988). Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte devel-opment in culture. Nature 333:562-565.
Rando TA (2006). Stem cells, ageing and the quest for immortality. Nature 441:1080-1086.
59 Reichenbach A, Wolburg H (2009). Structural association of astrocytes with neurons and vascualture: defining territorial boundaries. In: Parpura V, Haydon PG, edi-tors. Astrocytes in (Patho)Physiology of the Nervous system. New York: Springer;
2009, p. 251-286.
Reindl M, Linington C, Brehm U, Egg R, Dlitz E, Deisenhammer F, Poewe W, Berger T (1999). Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a com-parative study. Brain 122:2047-2056.
Rhodes KE, Raivich G, Fawcett JW (2006). The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation associated cytokines. Neuroscience 140:87-100.
Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M (1988). A role for platelet-derived growth factor in normal gliogenesis in the central nervous sys-tem. Cell 53:309-319.
Robertson NP, Clayton D, Fraser M, Deans J, Compston DA (1996a). Clinical concord-ance in sibling pairs with multiple sclerosis. Neurology 47:347-352.
Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA (1996b). Age-adjusted recurrence risks for children and siblings of patients with multiple sclero-sis. Brain 119:449-455.
Roosendaal SD, Moraal B, Pouwels PJ, Vrenken H, Castelijns JA, Barkhof F, Geurts JJ (2009). Accumulation of cortical lesions in MS: relation with cognitive impair-ment. Mult Scler 15:708-714.
Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glo-rioso JC, Comi G, Martino G (2001). Fibroblast growth factor-II gene therapy re-verts the clinical course and the pathological signs of chronic experimental auto-immune encephalomyelitis in C57BL/6 mice. Gene Ther 8:1207-1213.
60 Sasaki Y, Ohsawa K, Kanazawa H, Kohsaka S, Imai Y (2001). Iba1 is an
actin-cross-linking protein in macrophages/microglia. Biochem Biophys Res Commun 286:292-297.
Schousboe A, Sarup A, Bak LK, Waagepetersen HS, Larsson OM (2004). Role of as-trocytic transport processes in glutamatergic and GABAergic neurotransmission.
Neurochem Int 45:521-527.
Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J (1998). Oli-godendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121:2221-2228
Serafini B, Magliozzi R, Reynolds R, Franciotta D, Rosicarelli B, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899-2912.
Shields SA, Gilson JM, Blakemore WF, Franklin RJM (1999). Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotox-in-induced CNS demyelination. Glia 28:77-83.
Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M (2008). Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172:1053-1061.
Skripuletz T, Gudi V, Hackstette D, Stangel M (2011). De- and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the un-expected. Histol Histopathol 26:1585-1597.
Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baum-gärtner W, Stangel M (2013). Astrocytes regulate myelin clearance through re-cruitment of microglia during cuprizone-induced demyelination. Brain 136:147-167.
61 Slezak M, Pfrieger FW (2003). New roles for astrocytes: regulation of CNS
synapto-genesis. Trends Neurosci 26:531-535.
Sofroniev MV, Bush TG, Blumauer N, Kruger L, Mucke L, Johnson MH (1999). Ge-netically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice. Brain Research 835:91-95.
Stangel M, Pul R, Skripuletz T, Trebst C, Voss E, Gudi V (2011). Remyelination in Multiple Sclerosis. Neuroinflammation, Chapter 9; Elsevier Insights 193-223.
Talbott JF, Loy DN, Liu Y, Qiu MS, Bunge MB, Rao MS, Whittemore SR (2005). En-dogenous Nkx2.2+/Olig2+ oligodendrocytes precursor cells fail toremyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.Exp Neurol 192:11-24.
Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001). Control of synapse-number by glia. Science 291:657-661.
Ullian EM, Christopherson KS, Barres BA (2004). Role for glia in synaptogenesis. Glia 47:209-216.
Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, Armstrong RC (2007). Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66:975-988.
Voss EV, Skuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M (2012). Charac-terisation of microglia during de- and remyelination: can they create a repair pro-moting environment?Neurobiol Dis 45:519-528.
Walz W, Wuttke WA (1989). Resistance of astrocyte electrical membrane properties toacidosis changes in the presence of lactate. Brain Res 504:82-86.
62 Wang DD, Bordey A (2008). The astrocyte odyssey. Prog Neurobiol 86:342-367.
Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA (1998). Notch receptor activation inhibits oligodendrocyte differentiation.
Neuron 21:63-75.
Wang Z, Colognato H, ffrench-Constant C (2007). Contrasting effects of mitogenic growth factors on myelination in neuron-oligodendrocyte co-cultures. Glia 55:537-545.
Wang DD, Bordey A (2008). The astrocyte Odyssey. Prog Neurobiol 86:342-367.
Williams A, Piaton G, Lubetzki C (2007). Astrocytes − friends or foes in multiple scle-rosis? Glia 55:1300-1312.
Wilson HC, Onischke C, Scolding NJ, Raine CS (2006). Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 176:162-173.
Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G 2nd, Roy NS, Goldman SA (2004). Fetal and adult human oligodendrocyte progen-itor cell isolates myelinate the congenitally dysmyelinated brain. Nature Med 10:93-97.
Wolswijk G, Noble M (1992). Cooperation between PDGF and FGF converts slowly dividing O-2A adult progenitors to rapidly dividing cells with characteristics of O-2A perinatal progenitor cells. J Cell Biol 118:889-900.
Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ (2004). Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25:252-262.
63 Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard R, Barres BA (2012). Genomic
analysis of reactive astrocytes. J Neurosci 32:6391-6410.
Zeger M, Popken G, Zhang J, Xuan S, Lu QR, Schwab MH, Nave KA, Rowitch D, D'Ercole AJ, Ye P (2007). Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendro-cyte development and myelination. Glia 55:400-411.
Zhang SC, Ge B, Duncan ID (1999). Adult brain retains the potential to generate oli-godendroglial progenitors with extensive myelination capacity. Proc Natl Acad
Sci USA 96:4089-4094.
Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto G (2002). Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6:43-50.
64